Contributions of the Microbiome-Derived Metabolome for Risk Assessment and Prognostication of Pancreatic Cancer.
Ricardo A León-LetelierRongzhang DouJody VykoukalMichele T Yip-SchneiderAnirban MaitraEhsan IrajizadRanran WuJennifer B DennisonKim-An DoJianjun ZhangC Max SchmidtSamir M HanashJohannes F FahrmannPublished in: Clinical chemistry (2024)
The microbiome-derived metabolome holds considerable promise for risk assessment and prognostication of PDAC.